ArticleRadiation oncology (London, England)2025

Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort.

Wei-Xiang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.